Clinical Trials Directory

Trials / Completed

CompletedNCT02533908

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children: A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
402 (actual)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
2 Years – 16 Years
Healthy volunteers
Accepted

Summary

This study analyzes the analgesic efficacy and adverse events of nitrous oxide 70% combined with basic analgetics compared to nitrous oxide 70% with fentanyl intranasal for analgosedation for short and painful procedures in children.

Detailed description

Nitrous oxide 70% (N20 70%) combined with 30% oxygen meets many criteria of an ideal pain medication for procedural analgosedation in children. At the emergency department of the Children's Hospital of Zurich, Switzerland, N20 70% is regularly used for short and painful orthopaedic procedures, mostly for reduction of dislocated forearm or finger fractures. The analgesic efficacy of N20 70% still remains controversial. Therefore, all children who are eligible for N20 70% receive additionally either fentanyl or placebo intranasal and then their behavior, level of sedation and adverse events are measured during the painful procedure. The hypothesis is that a combination of N20 70% and fentanyl intranasal is not significant better than N20 70% combined with basic analgetics.

Conditions

Interventions

TypeNameDescription
DRUGFentanyl intranasalfentanyl is applied intranasally with a MAD (mucosal atomization device) prior to the application of nitrous oxide 70% analgosedation
DRUGNaCl 0.9% intranasalPlacebo is applied intranasally with a MAD (mucosal atomization device) Prior to the application of nitrous oxide 70% analgosedation

Timeline

Start date
2015-09-21
Primary completion
2017-10-12
Completion
2017-10-12
First posted
2015-08-27
Last updated
2017-10-26

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02533908. Inclusion in this directory is not an endorsement.